SMaRT Mom - Smartphone Management and Responsive Time for Breastfeeding Mothers
Launched by BAR-ILAN UNIVERSITY, ISRAEL · Sep 2, 2023
Trial Information
Current as of July 27, 2025
Recruiting
Keywords
ClinConnect Summary
The SMaRT Mom study is looking into how reducing smartphone use can help breastfeeding mothers and their infants. Smartphones are a big part of our lives, but they can distract mothers during important bonding time with their babies, which might affect how both the mother and baby feel and interact. This trial will evaluate a program designed to help mothers manage their smartphone use while breastfeeding, focusing on how this change impacts their confidence as mothers and the emotional development of their infants.
To participate in this study, mothers need to have an infant aged 3 to 6 months and show some signs of smartphone addiction. They should not have any serious health issues like neurological disorders, heart disease, anxiety, or depression. If you join the study, you can expect to learn strategies for reducing smartphone use and see how it affects your relationship with your baby. Overall, this research aims to better understand how technology influences early interactions between mothers and their infants in today's digital world.
Gender
FEMALE
Eligibility criteria
- Inclusion Criteria:
- • 3-6 months old infant
- • Smartphone Addiction Scale' cut-off (31 and above)
- Exclusion Criteria:
- • No neurological disorders
- • No heart disease
- • No anxiety and depression
- • No use of psychiatric drugs
About Bar Ilan University, Israel
Bar-Ilan University, located in Israel, is a leading academic institution renowned for its innovative research and commitment to advancing science and technology. The university actively engages in clinical trials across various disciplines, emphasizing interdisciplinary collaboration and the application of cutting-edge methodologies. With a strong focus on health sciences, Bar-Ilan University aims to improve patient outcomes through rigorous scientific inquiry and the development of novel therapeutic approaches. Its clinical trial initiatives are supported by a team of experienced researchers and healthcare professionals dedicated to translating research findings into effective clinical practices.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Ramat Gan, , Israel
Patients applied
Trial Officials
Ilanit Gordon, Prof.
Study Chair
Department of Psychology, Gonda Brain Research Center Bar-Ilan University
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported